Calendar Ultragenyx Pharmaceutical Inc.

Equities

RARE

US90400D1081

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 02:30:00 18/02/2026 am IST			5-day change	1st Jan Change
20.18 ^USD	-1.66%		-16.61%	-12.26%

13/02	Truist Cuts Price Target on Ultragenyx Pharmaceutical to $76 From $90, Keeps Buy Rating	MT
13/02	Ultragenyx Pharmaceutical Inc., Q4 2025 Earnings Call, Feb 12, 2026

Chart calendar Ultragenyx Pharmaceutical Inc.

af1b2ccdbf1e8fccc47753.deNaimliOIBUksZFiNawQVhLe0v0S8jqZuL6SXb_-1w.E6of4iE3afEYoZUX35DZdW0MJBrBIK6mF4zJBAWWliUclT76OS1xtSLQqQ~90ff107e6b4b23924aa1692ed9a976c2

Upcoming events on Ultragenyx Pharmaceutical Inc.

30/04/2026	Q1 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
30/07/2026	Q2 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
04/11/2026	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
18/02/2027	Q4 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format

Past events on Ultragenyx Pharmaceutical Inc.

13/02/2026	Q4 2025 Earnings Call
13/02/2026	Q4 2025 Earnings Release
13/01/2026	J.P. Morgan Healthcare Conference
03/12/2025	Evercore Healthcare Conference
03/12/2025	Citi Global Healthcare Conference
05/11/2025	Q3 2025 Earnings Call
05/11/2025	Q3 2025 Earnings Release
23/09/2025	Bank of America Global Healthcare Conference
10/09/2025	Morgan Stanley Global Healthcare Conference
04/09/2025	Cantor Global Healthcare Conference
06/08/2025	Q2 2025 Earnings Call
06/08/2025	Q2 2025 Earnings Release
10/06/2025	Goldman Sachs Global Healthcare Conference
15/05/2025	Annual General Meeting
13/05/2025	Bank of America Global Healthcare Conference
07/05/2025	Q1 2025 Earnings Call
07/05/2025	Q1 2025 Earnings Release
12/03/2025	Leerink Partners Global Healthcare Conference
11/03/2025	Barclays Global Healthcare Conference
03/03/2025	TD Cowen Healthcare Conference - Fireside Chat

Annual results

Fiscal Period	December	2022	2023	2024	2025	2026	2027
Net sales Million USD	Released Forecast Spread	363 362 0.43%	434 430 0.97%	560 555 1%	673 668 0.69%	762	1 063
EBITDA Million USD	Released Forecast Spread	-631 -608 -3.77%	-543 -549 1.02%	-500 -510 1.91%	0,00 -498 -	-399	-1,35
EBIT Million USD	Released Forecast Spread	-649 -640 -1.47%	-569 -563 -1.14%	-536 -531 -0.94%	-535 -512 -4.43%	-435	-17,4
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-702 -705 0.42%	-608 -616 1.21%	-568 -558 -1.64%	-571 -548 -4.18%	-471	-56,5
Net income Million USD	Released Forecast Spread	-707 -709 0.17%	-607 -617 1.65%	-569 -560 -1.65%	-575 -558 -3.1%	-457	-49,3
EPS USD	Released Forecast Spread	-10,1 -10,0 -0.82%	-8,25 -8,30 0.57%	-6,29 -6,19 -1.64%	-5,83 -5,65 -3.13%	-4,32	-0,38
Announcement Date		16/02/23	15/02/24	13/02/25	12/02/26

Quarterly results

Fiscal Period	September	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3
Net sales Million USD	Released Forecast Spread	109 116 -6.53%	147 123 19.33%	139 135 3.14%	165 159 3.89%	139 144 -3.57%	166 161 3.18%	160 167 -4.11%	207 202 2.55%	166	181	186	218	213	245	270
EBITDA Million USD	Released Forecast Spread	-157 -114 -37.8%	-107 -106 -1.8%	-123	-113 -129 12.25%	-134 -139 3.63%	-99,3 -124 19.94%	-162 -107 -51.05%	-111	-93,5	-86,0	-89,4
EBIT Million USD	Released Forecast Spread	-165 -133 -24.76%	-116 -134 13.19%	-132 -122 -7.97%	-122 -118 -3.34%	-143 -148 3.39%	-108 -118 8.89%	-171 -114 -49.96%	-114 -97,5 -16.93%	-133	-113	-104	-71,3	-81,1	-51,1	-21,8
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-170 -138 -23.09%	-131 -140 6.58%	-133 -134 0.3%	-133 -125 -7.04%	-150 -151 1.09%	-114 -126 9.57%	-180 -120 -49.58%	-128 -103 -24.31%	-145	-122	-107	-80,1	-94,7	-64,5	-35,5
Net income Million USD	Released Forecast Spread	-171 -140 -22.19%	-132 -140 6.32%	-134 -134 0.67%	-133 -126 -5.74%	-151 -157 3.66%	-115 -127 9.75%	-180 -121 -48.64%	-129 -109 -18.08%	-151	-123	-109	-78,2	-94,7	-64,5	-35,5
EPS USD	Released Forecast Spread	-2,03 -1,75 -15.88%	-1,52 -1,65 7.74%	-1,40 -1,48 5.66%	-1,39 -1,29 -7.73%	-1,57 -1,65 4.57%	-1,17 -1,30 9.83%	-1,81 -1,24 -46.23%	-1,29 -1,13 -14.23%	-1,42	-1,18	-0,99	-0,68	-0,51	-0,11	0,16
Announcement Date		02/05/24	01/08/24	05/11/24	13/02/25	06/05/25	05/08/25	04/11/25	12/02/26	-	-	-	-	-	-	-

Upcoming sector events for Ultragenyx Pharmaceutical Inc.

26/02/2026	SAREPTA THERAPEUTICS, INC.	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
30/04/2026	ULTRAGENYX PHARMACEUTICAL INC.	Q1 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
06/05/2026	SAREPTA THERAPEUTICS, INC.	Q1 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
30/07/2026	ULTRAGENYX PHARMACEUTICAL INC.	Q2 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
05/08/2026	SAREPTA THERAPEUTICS, INC.	Q2 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
04/11/2026	SAREPTA THERAPEUTICS, INC.	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
04/11/2026	ULTRAGENYX PHARMACEUTICAL INC.	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
18/02/2027	ULTRAGENYX PHARMACEUTICAL INC.	Q4 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
03/03/2027	SAREPTA THERAPEUTICS, INC.	Q4 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format

More events

Past sector events for Ultragenyx Pharmaceutical Inc.

13/02/2026	ULTRAGENYX PHARMACEUTICAL INC.	Q4 2025 Earnings Release
05/11/2025	ULTRAGENYX PHARMACEUTICAL INC.	Q3 2025 Earnings Release
04/11/2025	SAREPTA THERAPEUTICS, INC.	Q3 2025 Earnings Release
07/08/2025	SAREPTA THERAPEUTICS, INC.	Q2 2025 Earnings Release
06/08/2025	ULTRAGENYX PHARMACEUTICAL INC.	Q2 2025 Earnings Release
07/05/2025	SAREPTA THERAPEUTICS, INC.	Q1 2025 Earnings Release
07/05/2025	ULTRAGENYX PHARMACEUTICAL INC.	Q1 2025 Earnings Release
27/02/2025	SAREPTA THERAPEUTICS, INC.	Q4 2024 Earnings Release
14/02/2025	ULTRAGENYX PHARMACEUTICAL INC.	Q4 2024 Earnings Release
07/11/2024	SAREPTA THERAPEUTICS, INC.	Q3 2024 Earnings Release